082026-06

2026 ADA | CMS's Self-developed Innovative INHBE-Targeting siRNA Drug CMS-D008 Presents Its Preclinical Results

CMS Charity | Love Like Starlight: CMS Continues to Care for Children’s Growth

2026-06-01

Growing toward the light, together in warmth. With International Children’s Day approaching, China Medical System Holdings Limited (“CMS”), through its subsidiary Shenzhen Kangzhe, continued its long-standing philanthropic initiatives. Via the Charity Association of Shenzhen Nanshan, CMS donated funds to the Star Exceptional Children Rehabilitation Center in Nanshan District, Shenzhen. The donation will be used to upgrade teaching aids, add rehabilitation equipment, and provide support for frontline teachers—helping improve learning, rehabilitation, and living conditions for exceptional children. Over the years, CMS has stood side-by-side with the Center, witnessing every small step of progress in the rehabilitation and growth of these children. This enduring commitment stems from a deep compassion for special-needs children and a profound understanding of philanthropic values: their development demands patience, sustained support, and collective care from society. In addition, CMS donated 10 computers to the Green & Shine Foundation to help improve educational facilities in schools across central and western China, supporting daily teaching […]

CMS Wins Dual Honors at the 2026 “Golden Kunpeng”: “Best Listed Company” and “Most Investable Listed Company”

2026-05-27

On 26 May 2026, the 2026 Global Commercial Newspaper Economic Forum and the “Golden Kunpeng” China Financial Value Ranking Awards Ceremony, co-hosted by the Global Commercial Newspaper Alliance and Hong Kong Commercial Daily, was held in Hong Kong. China Medical System Holdings Limited (“CMS” or the “Group”) stood out among a broad field of participating companies on the strength of its solid fundamentals and sustainable growth outlook, winning two awards: “Best Listed Company” and “Most Investable Listed Company”. Meanwhile, based on the Group’s overall performance in innovative R&D, growth and liquidity, the Group was officially included as a constituent of the Hong Kong Commercial Daily Technology Index.     The “Best Listed Company” award provides a comprehensive assessment across core indicators including financial performance, corporate governance, ESG practices and market influence, while the “Most Investable Listed Company” award focuses on dimensions such as the sustainability of the business model, financial soundness and industry growth potential. […]